AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Chemical Business NewsBase - The Independent)
GlaxoSmithKline is targeting more than #2 bn in annual sales from five blockbuster vaccines it promised yesterday will be ready for launch by the end of the decade. The company had previously boasted of the prospects for its forthcoming cervical cancer vaccine, Cervarix, and said yesterday it would be joined by three new jabs to protect toddlers from diseases including meningitis, and ...